Advisor Group Holdings, Inc. Kintara Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.14 - $0.5 $3,526 - $12,596	-25,192 Reduced 34.34%	48,175 $13,000
Q1 2022 May 04, 2022	BUY	$0.31 - $0.55 $22,508 - $39,933	72,607 Added 9553.55%	73,367 $130,000
Q3 2021 Nov 05, 2021	SELL	$0.82 - $2.3 $4,630 - $12,988	-5,647 Reduced 88.14%	760 $1,000
Q2 2021 Aug 02, 2021	BUY	$1.26 - $2.4 $4,532 - $8,632	3,597 Added 128.01%	6,407 $14,000
Q1 2021 May 13, 2021	BUY	$1.32 - $2.74 $3,709 - $7,699	2,810 New	2,810 $5,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.